SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-039566
Filing Date
2021-06-10
Accepted
2021-06-10 17:23:48
Documents
2
Period of Report
2021-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 14795
2 EX-24 DOCUMENT attachment1.htm EX-24 4262
  Complete submission text file 0001209191-21-039566.txt   20509
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Issuer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYROS PHARMACEUTICALS, INC. 35 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address
Stephens Kristin (Reporting) CIK: 0001865490 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37813 | Film No.: 211009044